![](https://pharma.industry-report.net/wp-content/uploads/2018/10/usfda-1.png)
DRL receives USFDA approval for extended-release Dipyridamole capsules
Dr Reddy’s Laboratories Ltd has received USFDA approval for Aspirin and extended-release Dipyridamole capsules. The drug is a therapeutic equivalent generic version of Aggrenox (Aspirin […]